Blood Cancers and Blood Disorders Team

Dr. Brian Druker (left) and Dr. Gordon Mills talking at the OHSU Knight Cancer Research building.
Research is a driving force in our patient care. Dr. Brian Druker (left), Knight Cancer Institute director, and Dr. Gordon Mills are internationally recognized cancer scientists. Mills, who also holds a Ph.D., is director of precision oncology.

Your care team at the OHSU Knight Cancer Institute will include world leaders in treating blood disorders and blood cancers. Our director, Dr. Brian Druker, played a central role in developing  Gleevec, a lifesaving medication for chronic myelogenous leukemia. We are also helping lead Beat AML, a national effort to find new treatments for acute myeloid leukemia.

We offer you:

  • Doctors who are also part of OHSU’s Center for Hematologic Malignancies, with detailed expertise in even rare blood diseases.
  • Team-based care, with specialists meeting often to discuss each patient and develop the most effective treatment options.
  • Deep specialization, helping us precisely match treatments to your specific blood cancer or disorder.
  • An emphasis on research that translates laboratory findings into patient care.
  • Access to clinical trials, giving our patients the chance to try promising new therapies.

Blood cancers and blood disorders

Bone marrow/stem cell transplants

  • Jolene Kemp, R.N.
  • Anne Kratz, R.N.
  • Bashi Ratterree, R.N.
  • Florence Seelig, R.N.

For patients

Call 503-494-7999 to:

  • Request an appointment
  • Seek a second opinion
  • Ask questions

Locations

Parking is free for patients and their visitors.

Center for Health & Healing Building 2
3485 S. Bond Ave.
Portland, OR 97239

Map and directions

Refer a patient